Filter
3068
Filtered Results: 3068
Text search:
National
Reproductive
Health
Programme
Ministry
of
Health
Featured
Recommendations
202
New Publications
1108
Language
Document type
No document type
1998
Studies & Reports
465
Guidelines
272
Strategic & Response Plan
121
Manuals
115
Training Material
39
Situation Updates
29
Fact sheets
16
Infographics
6
Resource Platforms
3
Brochures
2
App
1
Online Courses
1
Countries / Regions
India
182
Kenya
158
Nepal
109
Uganda
109
Ethiopia
99
Nigeria
98
Global
93
Sierra Leone
91
Tanzania
84
Malawi
81
Zambia
76
Rwanda
73
Liberia
71
Myanmar / Burma
71
Bangladesh
61
Congo, Democratic Republic of
56
Namibia
56
Ghana
48
Senegal
42
Lesotho
35
Ukraine
33
Haiti
32
Syria
30
Africa
30
Zimbabwe
28
Latin America and the Carribbean
27
Burkina Faso
26
Cambodia
25
Botswana
25
Mozambique
24
Western and Central Europe
23
Indonesia
23
South Africa
22
Benin
21
Cameroon
19
Guinea
19
Asia
19
South Sudan
19
South–East Asia Region
17
Madagascar
14
Eswatini/ Swaziland
14
East and Southern Africa
12
Eastern Europe
11
Yemen
9
Central African Republic
9
Pakistan
9
Albania
8
Philippines
8
Lebanon
8
Brazil
8
Russia
8
Somalia
7
Tajikistan
6
Afghanistan
6
Venezuela
6
Jordan
6
West and Central Africa
6
Middle East and North Africa
6
Paraguay
6
Sudan
6
Colombia
5
Thailand
5
Togo
5
Mali
5
Niger
4
Germany
4
Eastern Europe and Central Asia
4
Moldova
4
Georgia
4
Timor Leste/ East Timor
3
Burundi
3
Peru
3
Western Pacific Region
3
Sri Lanka
3
Romania
3
Palestine
3
Mexico
2
Serbia
2
Turkey
2
China
2
Canada
2
Laos
2
Kyrgyzstan
2
Congo-Brazzaville
2
Bulgaria
2
Armenia
2
Guinea-Bissau
2
Hungary
2
North America
2
Turkmenistan
2
Jamaica
2
Japan
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Vietnam
2
Slovakia
2
Poland
2
Angola
2
Iraq
2
Ecuador
2
North Macedonia
1
Gambia
1
Chile
1
Iran
1
Croatia
1
Denmark
1
France
1
Maldives
1
Portugal
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Latvia
1
Bolivia
1
Papua New Guinea
1
Djibouti
1
Egypt
1
Honduras
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1789
Women & Child Health
195
Clinical Guidelines
138
Public Health
123
Key Resources
123
Capacity Building
47
Pharmacy & Technologies
17
Toolboxes
HIV
320
COVID-19
125
Mental Health
100
TB
91
Conflict
86
Caregiver
76
Disability
63
Ebola & Marburg
56
Planetary Health
52
NTDs
45
Global Health Education
41
Refugee
36
AMR
36
Natural Hazards
32
Malaria
32
Rapid Response
31
Pharmacy
31
Health Financing Toolbox
31
2.0 Rapid Response
27
NCDs
18
Zika
15
Cholera
5
Specific Hazards
4
Social Ethics
4
Polio
4
Typhoon
3
Emergency response framework, 2nd ed.
recommended
The purpose of this Emergency Response Framework (ERF) is to clarify WHO’s roles and responsibilities in this regard and to provide a common approach for its work in emergencies. Ultimately, the ERF requires WHO to act with urgency and predictability to best serve and be accountable to populations...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Lessons and best practices in empowering pastoralist communities to prevent HIV infection and reduce the impact of AIDS in Ethiopia. Briefing Paper
The Demographic Dividend study on Rwanda assessed the socio-economic and human development potential of our country in the short, medium and long-term period using a comprehensive approach. It generated relevant policy and programme information to guide a well-informed polciy required to propel Rwan...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
Manual for step-by-step risk management for safely managed sanitation systems. 2nd edition.
This Sanitation safety planning (SSP) manual provides practical, step-by-step guidance to assist in the implementation of the 2018 World Health Organization (WHO) Guidelines on sanitation and health and the ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Response to the tropical cyclone in southern Africa
Ebola virus disease outbreak in the Democratic Republic of the Congo
Meningitis outbreak in Togo
Lassa fever outbreak in Liberia.
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
For several decades, civil society organisations (CSOs) in Nigeria have been advocating for increased resources for family planning (FP) and reproductive health (RH) services and commodities. To help CSOs in Nigeria understand and actively participate in the budget process at the state level, a team...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
